Anthropic Pursues $1.5 Trillion Valuation Target in IPO

The news is not directly related to NVDA; Anthropic's IPO valuation brings AI capital flows into focus but does not offer a clear catalyst for NVDA. The technical picture is weak: the price is below the SMA20 and SMA50, MACD is in negative territory, and a sharp 10% drop over 24 hours has broken momentum. RSI at 36 is close to oversold territory; short-term rebound buying may appear, but the trend is downward. Although the news supporting appetite for AI spending is positive over the medium term, its impact over a 1-3 day window is limited and uncertain. Therefore, a slight downward bias is assessed with low-to-medium confidence.

The news does not directly concern AMD; while Anthropic's IPO plans demonstrate appetite for the artificial intelligence sector, they offer no concrete impact on AMD's revenue. On the technical side, the stock fell 8.9% over 24 hours, dropping just below its SMA20, with MACD in negative territory and RSI at 45—weak but not oversold. The notable distance above the SMA50 (489) indicates the short-term trend has deteriorated. Sector sentiment from the news may be marginally positive, but price action dominates. For this reason, the bias over 1-3 days is neutral, and any rebound buying may remain weak.

The news reflects not TSM's direct fundamentals but the valuation appetite in the artificial intelligence sector; therefore, its impact on TSM may remain indirect and limited. The price at 375.29 is trading just below the SMA20 (377.87) and markedly below the SMA50 (399.53), indicating a weak short-term trend. RSI at 41.96 is in the neutral-to-weak zone, while MACD is negative and below the signal line; momentum is downward but not oversold. After the 7.7% decline over 24 hours, rebound buying may be seen, but the news alone is not sufficient to determine direction. In the short term, a sideways-to-range-bound course with a slight downward bias is expected.

AVGO fell sharply by 11.7% over the past 24 hours to 293.32, with its RSI at 29.7 approaching oversold territory; MACD remains in negative territory below its signal line. The price is clearly below the SMA20 and SMA50, indicating a weak short-term trend. Anthropic's $1.5 trillion IPO target is not news directly concerning AVGO; it could be perceived as an indirect signal of appetite for AI valuations, but it is unlikely to reverse the current selling pressure on its own. Although oversold conditions may open the door to bargain-hunting rebounds, downside risks remain more dominant in the 1-3 day outlook. I therefore forecast a cautious downward bias.